USD 1.15 billion
Oncology Ablation Market Size, Share, Growth Analysis, By Technology(Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation.), By Treatment(Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation.), By Application(Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35B2038 |
Region:
Global |
Published Date: April, 2024
Pages:
225
|Tables:
93
|Figures:
67
Oncology Ablation Market Insights
Oncology Ablation Market size was valued at USD 1.15 billion in 2022 and is poised to grow from USD 1.31 billion in 2023 to USD 3.62 billion by 2031, growing at a CAGR of 13.6% in the forecast period (2024-2031).
Growing need for safer therapeutic choices and rising incidence of cancer are two key drivers of the market expansion. In low-income nations, the number of new cancer cases is anticipated to rise by more than 80%, compared to a rate of 41% in high-income nations. The market is anticipated to increase substantially in the forecast period due to the therapeutic choices that are currently available and the rising demand for minimally invasive and non-invasive treatments.
The demand for advanced tumour ablation techniques is anticipated to increase throughout the forecast period as surgeons and patients become more inclined toward minimally invasive procedures due to the advantages of quick recovery, patient comfort, and shorter recovery times. Comparing advanced tumour ablation procedures to conventional therapies, advanced tumour ablation operations are typically conducted on an outpatient basis and do not require any hospital admission, considerably lowering the overall cost of healthcare. The preferred treatment for tumours of lesser sizes is ablative surgery. As a result, the volume of its procedures is indirectly influenced by the yearly cancer screening rates.
US Oncology Ablation Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Surgical Ablation
Fastest Growth
Percutaneous Ablation
Growth Rate
13.6% CAGR
Global Oncology Ablation Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Oncology Ablation Market Segmental Analysis
Global Oncology Ablation Market is segmented based on the technology, treatment, application and region. Based on the technology, the Global Oncology Ablation Market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation. Based on the treatment, the market has been segmented into Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation. Based on the application, the market has been segmented into Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Oncology Ablation Market Analysis by Treatment
The surgical ablation segment is dominated the market and held the largest revenue share of over 35.2% in 2021. The reasons expected to drive the market growth include rising rates of breast and liver cancer as well as the lack of sophisticated tumour ablation treatments for these specific organs.
The percutaneous ablation segment is fastest growing segment and anticipated to increase during the forecast period. Faster healing, little scarring, and better safety are all benefits of these procedures. Additionally, it is projected that features such a short recovery period after surgery, patient comfort, and cost effectiveness would further increase segment demand. However, it is anticipated that the system’s increased complexities may restrain its expansion, particularly in institutions with a shortage of qualified personnel.
Oncology Ablation Market Analysis by Application
Liver cancer dominated the market with a revenue share of over 20.2% in 2021. This is attributed by the increasing prevalence of primary liver cancer and bile duct cancer. The increasing demand for cure liver cancer at earliest stage are influenced the market growth. Ablation method is recommended for small, localized liver tumors as it is recommended that the area treated with radiofrequency ablation should be 2 centimeters or less.
Renal or kidney cancer is fastest growing segment and lucrative growth of CAGR during the forecast period. Treatment for kidney tumours using radiofrequency and microwave ablation technology is effective. Patients with solitary kidneys, tumours smaller than 4 cm, and a delayed pace of post-operative recovery are candidates for kidney tumour ablation.
Global Oncology Ablation Market Size By Treatment, 2021-2028 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Oncology Ablation Market Regional Insights
North America dominated the global market with a revenue share of over 30.1% in 2021. Government support for high-quality healthcare, high purchasing power parity, the availability of reimbursements, and the rising incidence of cancer are some of the main drivers of this region’s growth. The Patient Protection and Affordable Care Act (PPACA), for instance, lowers the cost of healthcare for both individuals and the government in the United States by promoting the quality and accessibility of healthcare through health coverage policies. Another important growing component is the precision medicine project, which develops personalised solutions for particular illness characteristics. Therefore, it is projected that such government initiatives will enhance the healthcare system as a whole, thereby spurring market growth.
Asia Pacific is fastest growing region and expected to register the highest CAGR during the forecast period. Growth prospects are created by the rising number of patients and significant healthcare providers in quickly emerging nations like China and India. Throughout addition, healthcare utilisation in Asia and the Pacific is rising thanks to government support. For instance, the Health Minister Cancer Patient Fund (HMCPF) programme of the Indian government offers financial aid to underprivileged cancer patients. Over the projection period, this is expected to increase demand for tumour ablation devices in this area.
Global Oncology Ablation Market By Geography, 2021-2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Oncology Ablation Market Dynamics
Oncology Ablation Market Driver
- Increasing Demand for Advanced Oncology Ablation
The demand for advanced tumour ablation techniques is anticipated to increase throughout the forecast period as surgeons and patients become more inclined toward minimally invasive procedures due to the advantages of quick recovery, patient comfort, and shorter recovery times.
Oncology Ablation Market Restraint
- Complexities of Ablation Treatment to Hamper Market
For many solid organ cancers, tumour ablation therapy is becoming a more realistic treatment option. Complexities could increase along with the number of processes. Blood loss and wounds to the target organ are the most frequent side effects of ablation. These side effects are categorized as per their related threat. Side effects linked with these operations can hinder the market growth.
Request Free Customization of this report to help us to meet your business objectives.
Oncology Ablation Market Competitive Landscape
Global Oncology Ablation Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Oncology Ablation Market Top Player's Company Profiles
- Angiodynamics (Covidien)
- Boston Scientific Corporation
- Medtronic Plc
- Ethicon, Inc.
- Galil Medical Inc.
- Misonix Inc.
- HealthTronics
- Mermaid Medical
- Theraclion
- Chongqing Haifu Medical Technology Co., Ltd.
- HS Hospital Service S.P.A
Oncology Ablation Market Recent Developments
- In June 2022, IceCure Medical Ltd. Submitted a regulatory filing to the Brazilian Health Regulatory Agency (“ANVISA”) for the approval of ProSense, an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone, and lung cancer.
- In December 2021 by Ethicon Inc. to evaluate the effectiveness and safety of the new wave-certus microwave ablation system in Chinese patients with primary or secondary tumors in the lung.
- In September 2021, Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer.
Oncology Ablation Key Market Trends
- Cooled Radiofrequency Probes Gaining Traction
Market player are focusing on technological advancements to improve accuracy, portability, and cost-effectiveness. HIFU, cryoablation, and image-guided equipment are three prominent examples of these technological developments. One of the upcoming approaches that is projected to significantly contribute to market growth is the use of the cooled radiofrequency denervation technique with internally cooled radiofrequency probes to increase the size of the lesion. This procedure makes it possible to completely denervate the sacroiliac joint, which aids in the treatment of pain.
Oncology Ablation Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our Global Oncology Ablation Market analysis, North America is expected to capture higher market share, the growth of the region is attributed to the availability of reimbursements, and the rising incidence of cancer. US has emerged as a significant contributor to market growth in North America. In terms of treatment, the surgical ablation segment dominates the marine hybrid propulsion market. This segment's leading position can be attributed to its rising rates of breast and liver cancer as well as the lack of sophisticated tumour ablation treatments for these specific organs. In terms of application, the liver cancer application led the market and is predicted to grow at the fastest rate.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.15 billion |
| Market size value in 2031 | USD 3.62 billion |
| Growth Rate | 13.6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Oncology Ablation Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Oncology Ablation Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Oncology Ablation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oncology Ablation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oncology Ablation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Oncology Ablation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
